December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

1.680 -0.320 (-16.00%)
Delayed Quote Updated: 2:55 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about SciSparc Ltd. - Ordinary Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
18 19 Next >
News headline image
Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
From SciSparc Ltd
Via GlobeNewswire
News headline image
Why Is SciSparc (SPRC) Stock Up 50% Today? ↗
News of an investment fund inking an equity purchase agreement with SciSparc is boosting underlying credibility and lifting SPRC stock. 
Via InvestorPlace
News headline image
Why Is SciSparc (SPRC) Stock Up 25% Today? ↗
With SciSparc announcing positive results stemming from its joint venture, the drug discovery implications are boosting SPRC stock. 
Via InvestorPlace
News headline image
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More ↗
Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available. 
Via Benzinga
News headline image
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares... 
Via Benzinga
News headline image
Crude Oil Rises Over 1%; DuPont Shares Plunge ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The Dow traded up 0.36% to 38,040.66 while the NASDAQ rose 0.97% to 15,574.97. The... 
Via Benzinga
Topics Stocks
News headline image
What's Going On With SciSparc Ltd Stock? ↗
SciSparc Ltd. (NASDAQ: SPRC) shares are trading higher Wednesday. 
Via Benzinga
News headline image
Why SciSparc Ltd Stock Is Blasting Higher ↗
SciSparc Ltd. 
Via Benzinga
News headline image
Why SciSparc Stock Is Lighting Up ↗
SciSparc Ltd. shares are trading higher Wednesday after the company announced that it has entered into a standby equity purchase agreement with YA II PN, Ltd., a fund managed by Yorkville Advisors... 
Via Benzinga
News headline image
Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales ↗
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.29% to 38,013.76 while the NASDAQ... 
Via Benzinga
Topics Stocks
News headline image
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million
From SciSparc Ltd
Via GlobeNewswire
News headline image
Why Is Clearmind (CMND) Stock Up 40% Today? ↗
The jump in Clearmind sent its market cap to $6 million. The study of psychedelic compounds to treat mental illness is growing. 
Via InvestorPlace
News headline image
SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments
From SciSparc Ltd
Via GlobeNewswire
News headline image
Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based Treatments
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700... 
Via Benzinga
News headline image
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in Israel
From SciSparc Ltd
Via GlobeNewswire
News headline image
Why Is Clearmind Medicine (CMND) Stock Up 50% Today? ↗
Psychedelic-medicine specialist Clearmind Medicine posted encouraging study results, leading to a significant boost in CMND stock. 
Via InvestorPlace
News headline image
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More ↗
Defense Dept. Funds Ketamine Study For PTSD Treatment  
Via Benzinga
News headline image
Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Adopts Limited Duration Shareholder Rights Plan
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment
From SciSparc Ltd
Via GlobeNewswire
News headline image
EXCLUSIVE: Clearmind Medicine's Psychedelic-Based Treatment Shows Encouraging Preclinical Activity In Obesity, Metabolic Disorders ↗
Clearmind Medicine Inc (NASDAQ: CMND) has released results from its pre-clinical trial of the combination therapy. 
Via Benzinga
News headline image
What's Going On With SciSparc Shares Today? ↗
SciSparc Ltd (NASDAQ: SPRC) shares are trading lower Monday. The company announced results for MitoCareX Bio with its drug discovery platform. 
Via Benzinga
News headline image
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
From SciSparc Ltd
Via GlobeNewswire
News headline image
New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc, Deere & Company, Baidu, Marathon Digital, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗
U.S. stocks showed a positive trend on Wednesday. The Dow Jones index rose by approximately 184 points, marking an increase of 0.5% to 35,273.03. 
Via Benzinga
Topics Stocks
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.